Product Code: ETC8842133 | Publication Date: Sep 2024 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Shubham Deep | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Genomics is playing a crucial role in cancer care in the Philippines by enabling early detection, targeted therapies, and personalized treatment plans. The increasing prevalence of cancer and the growing adoption of molecular diagnostics are driving demand for genomic-based cancer treatments. Government initiatives aimed at improving cancer care infrastructure are also supporting market growth.
The increasing prevalence of cancer in the Philippines and the need for more effective treatment strategies are driving the adoption of genomics in cancer care. Precision oncology approaches based on genomic profiling are improving treatment outcomes and minimizing side effects. Advances in liquid biopsy and next-generation sequencing (NGS) are enabling non-invasive cancer diagnostics and monitoring. Additionally, growing research investments in cancer genomics are further propelling market growth.
The application of genomics in cancer care in the Philippines faces challenges due to high testing costs, limited infrastructure, and a lack of trained oncogenomic specialists. Cancer genomic testing is expensive, making it unaffordable for many patients. The country has a limited number of specialized genetic testing laboratories, resulting in long turnaround times and reliance on foreign facilities. Additionally, few oncologists have formal training in genomics, slowing the adoption of precision medicine in cancer treatment.
The growing focus on precision medicine and early cancer detection is driving the demand for genomics in cancer care in the Philippines. Investment opportunities exist in genetic testing services, oncology-focused genomic research, and bioinformatics platforms. With increasing government initiatives supporting cancer care and personalized treatment plans, partnerships with healthcare institutions and research centers can provide substantial growth potential for investors.
The Philippine Cancer Control Program integrates genomics into cancer diagnosis and treatment. The DOH has policies to promote the use of genomic testing for early detection and personalized cancer therapies. However, access to genomic-based cancer treatments remains limited due to cost constraints. The government is working towards expanding PhilHealth coverage for cancer-related genomic tests and therapies.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Genomics In Cancer Care Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Genomics In Cancer Care Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Genomics In Cancer Care Market - Industry Life Cycle |
3.4 Philippines Genomics In Cancer Care Market - Porter's Five Forces |
3.5 Philippines Genomics In Cancer Care Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Philippines Genomics In Cancer Care Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 Philippines Genomics In Cancer Care Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Philippines Genomics In Cancer Care Market Revenues & Volume Share, By End-User, 2021 & 2031F |
4 Philippines Genomics In Cancer Care Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Philippines Genomics In Cancer Care Market Trends |
6 Philippines Genomics In Cancer Care Market, By Types |
6.1 Philippines Genomics In Cancer Care Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Philippines Genomics In Cancer Care Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Philippines Genomics In Cancer Care Market Revenues & Volume, By Instruments, 2021- 2031F |
6.1.4 Philippines Genomics In Cancer Care Market Revenues & Volume, By Consumables, 2021- 2031F |
6.1.5 Philippines Genomics In Cancer Care Market Revenues & Volume, By Services, 2021- 2031F |
6.2 Philippines Genomics In Cancer Care Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 Philippines Genomics In Cancer Care Market Revenues & Volume, By PCR, 2021- 2031F |
6.2.3 Philippines Genomics In Cancer Care Market Revenues & Volume, By Genome Sequencing, 2021- 2031F |
6.2.4 Philippines Genomics In Cancer Care Market Revenues & Volume, By Nucleic Acid Extraction & Purification, 2021- 2031F |
6.2.5 Philippines Genomics In Cancer Care Market Revenues & Volume, By Microarray, 2021- 2031F |
6.2.6 Philippines Genomics In Cancer Care Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Philippines Genomics In Cancer Care Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Philippines Genomics In Cancer Care Market Revenues & Volume, By Diagnostics, 2021- 2031F |
6.3.3 Philippines Genomics In Cancer Care Market Revenues & Volume, By Personalized Medicine, 2021- 2031F |
6.3.4 Philippines Genomics In Cancer Care Market Revenues & Volume, By Drug Discovery & Development, 2021- 2031F |
6.3.5 Philippines Genomics In Cancer Care Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Philippines Genomics In Cancer Care Market, By End-User |
6.4.1 Overview and Analysis |
6.4.2 Philippines Genomics In Cancer Care Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Philippines Genomics In Cancer Care Market Revenues & Volume, By Research Institutes, 2021- 2031F |
6.4.4 Philippines Genomics In Cancer Care Market Revenues & Volume, By Others, 2021- 2031F |
7 Philippines Genomics In Cancer Care Market Import-Export Trade Statistics |
7.1 Philippines Genomics In Cancer Care Market Export to Major Countries |
7.2 Philippines Genomics In Cancer Care Market Imports from Major Countries |
8 Philippines Genomics In Cancer Care Market Key Performance Indicators |
9 Philippines Genomics In Cancer Care Market - Opportunity Assessment |
9.1 Philippines Genomics In Cancer Care Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Philippines Genomics In Cancer Care Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.3 Philippines Genomics In Cancer Care Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 Philippines Genomics In Cancer Care Market Opportunity Assessment, By End-User, 2021 & 2031F |
10 Philippines Genomics In Cancer Care Market - Competitive Landscape |
10.1 Philippines Genomics In Cancer Care Market Revenue Share, By Companies, 2024 |
10.2 Philippines Genomics In Cancer Care Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |